Bioactive glass nanoparticles with negative zeta potential

The purpose of this work was to produce and characterize SiO2–CaO–P2O5 bioactive glass nanoparticles with negative zeta potential for possible use in biomedical applications. 63S bioactive glass was obtained using the sol–gel method. X-ray fluorescence (XRF) spectroscopy and dispersive X-ray analysis (EDX) confirmed the preparation of the 63S bioactive glass with 62.17% SiO2, 28.47% CaO and 9.25% P2O5 (in molar percentage). The in vitro apatite forming ability of prepared bioactive glass was evaluated by Fourier transform infrared spectroscopy (FTIR) after immersion in simulated body fluid (SBF). The result showed that high crystalline hydroxyapatite can form on glass particles. By the gas adsorption (BET method), particle specific surface area and theoretical particle size were 223.6 ± 0.5 m2/g and ∼24 nm, respectively. Laser dynamic light scattering (DLS) indicated particles were mostly agglomerated and had an average diameter between 100 and 500 nm. Finally, using laser Doppler electrophoresis (LDE) the zeta potential of bioactive glass nanoparticles suspended in physiological saline was determined. The zeta potential was negative for acidic, neutral and basic pH values and was −16.18 ± 1.8 mV at pH 7.4. In summary, the sol–gel derived nanoparticles revealed in vitro bioactivity in SBF and had a negative zeta potential in physiological saline solution. This negative surface charge is due to the amount and kind of the ions in glass structure and according to the literature, promotes cell attachment and facilitates osteogenesis. The nanometric particle size, bioactivity and negative zeta potential make this material a possible candidate for bone tissue engineering.